Skip to main content
lexblog.com/lib/YMFA501Bviewrecordjson
LEX-WK-YMFA501Bcrawled 2020-11-24 07:46Z

Big Pharma to Face Off at Federal Circuit Oral Arguments Over Antibody Genus Patentability

Caitlin M. Wilmot · Biosimilars Law Bulletin · Published November 24, 2020

Work details

firm or organization
Rothwell Figg
published
2020-11-24

Citation

Caitlin M. Wilmot, Big Pharma to Face Off at Federal Circuit Oral Arguments Over Antibody Genus Patentability, Biosimilars Law Bulletin (November 24, 2020) [The Library at LexBlog, LEX-WK-YMFA501B, lexpid.org/YMFA501B]